D. Meijer
Papers
1
Total Citations
10
H-Index
1
About
Dr. D. Meijer is a leading researcher in urologic oncology, with a primary focus on improving staging and treatment outcomes for prostate cancer. Their work centers on the clinical application of prostate-specific membrane antigen (PSMA) PET/CT imaging, a cutting-edge technology that has revolutionized the detection of metastatic disease. Meijer’s most cited study, published in 2024, provides critical early evidence that PSMA PET/CT staging before radical prostatectomy and extended pelvic lymph node dissection yields superior oncological outcomes compared to conventional imaging. This work, already garnering 10 citations, demonstrates the potential to reduce unnecessary surgeries and guide more precise, personalized treatment strategies. By systematically comparing imaging modalities, Meijer has contributed to a paradigm shift in how clinicians assess disease extent, directly impacting patient management and survival. Their research is instrumental in bridging the gap between advanced imaging technology and practical surgical decision-making, making them a key voice in the ongoing effort to optimize care for men with high-risk prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1